|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| G01N 33/53 | (2006.01) | ||
| A61P 37/00 | (2006.01) |
| (11) | Number of the document | 3527588 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19165269.2 |
| Date of filing the European patent application | 2013-05-13 | |
| (97) | Date of publication of the European application | 2019-08-21 |
| (45) | Date of publication and mention of the grant of the patent | 2025-01-15 |
| (46) | Date of publication of the claims translation | 2025-02-25 |
| (30) | Number | Date | Country code |
| 201208370 | 2012-05-14 | GB |
| (72) |
FINNEY, Helene Margaret , GB
LAWSON, Alastair David Griffiths , GB
SHAW, Stevan Graham , GB
SMITH, Bryan John , GB
TYSON, Kerry Louise , GB
KEVORKIAN, Lara , GB
MEIER, Christoph , GB
ATHERFOLD, Paul Alan , GB
SARKAR, Kaushik , GB
|
| (73) |
UCB Biopharma SRL ,
Allée de la Recherche 60, 1070 Brussels,
BE
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Anti-FcRn antikūnai |
| ANTI-FCRN ANTIBODIES |
| Payment date | Validity (years) | Amount | |
| 2025-03-13 | 13 | 289.00 EUR |
| 2026-05-13 |